This company has no dividend history.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
No dividend history found in company filings.
Does Medios (ILM1.XETR) pay a dividend?
Medios (ILM1.XETR) has never paid a dividend. It returns cash through buybacks instead, at roughly a 4.4% buyback yield over the last twelve months. The business does generate free cash flow of €27 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Medios (ILM1.XETR) pay a dividend?+
No. Medios (ILM1.XETR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does Medios return cash to shareholders?+
Through share buybacks rather than dividends. Over the last twelve months Medios reduced its share count at a rate equivalent to a 4.4% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.
Could Medios afford to pay a dividend?+
On the numbers, yes. Medios generated €27 million of free cash flow, which is about €1.08 per share. If it paid out half of that, the dividend would be roughly €0.54 per share, a yield of about 4.7% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Medios.
Peers
Medical Distribution · Pick stocks to compare with ILM1.XETR
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ILM1.XETR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.